Literature DB >> 32348987

White Matter Alterations in Fmr1 Knockout Mice during Early Postnatal Brain Development.

Da Shi1,2, Su Xu1, Jiachen Zhuo1, Mary C McKenna3,4, Rao P Gullapalli5,6,7.   

Abstract

Fragile X syndrome (FXS) is the most commonly inherited form of intellectual disability ascribed to the autism spectrum disorder. Studies with FXS patients have reported altered white matter volume compared to controls. The Fmr1 knockout (KO) mouse, a model for FXS, showed evidence of delayed myelination during postnatal brain development. In this study, we examined several white matter regions in the male Fmr1 KO mouse brain compared to male wild-type (WT) mice at postnatal days (PND) 18, 21, 30, and 60, which coincide with critical stages of myelination and postnatal brain development. White matter volume, T2 relaxation time, and magnetization transfer ratio (MTR) were measured using magnetic resonance imaging and myelin content was determined with histological staining of myelin. Differences in the developmental accumulation of white matter and myelin between Fmr1 KO and WT mice were observed in the corpus callosum, external and internal capsules, cerebral peduncle, and fimbria. Alterations were more predominant in the external and internal capsules and fimbria of Fmr1 KO mice, where the MTR was lower at PND 18, then elevated at PND 30, and again lower at PND 60 compared to the corresponding regions in WT mice. The pattern of changes in MTR were similar to those observed in myelin staining and could be related to the altered protein synthesis that is a hallmark of FXS. While no significant changes in white matter volumes and T2 relaxation time between the Fmr1 KO and WT mice were observed, the altered pattern of myelin staining and MTR, particularly in the external capsule, reflecting the abnormalities associated with myelin content is suggestive of a developmental delay in the white matter of Fmr1 KO mouse brain. These early differences in white matter during critical developmental stages may contribute to altered brain networks in the Fmr1 KO mice.
© 2020 S. Karger AG, Basel.

Entities:  

Keywords:  Fmr1 knockout; Fragile X syndrome; Magnetization transfer; Myelination; T2 relaxation

Year:  2020        PMID: 32348987      PMCID: PMC7528612          DOI: 10.1159/000506679

Source DB:  PubMed          Journal:  Dev Neurosci        ISSN: 0378-5866            Impact factor:   2.984


  63 in total

1.  Dendritic spine instability and insensitivity to modulation by sensory experience in a mouse model of fragile X syndrome.

Authors:  Feng Pan; Georgina M Aldridge; William T Greenough; Wen-Biao Gan
Journal:  Proc Natl Acad Sci U S A       Date:  2010-09-22       Impact factor: 11.205

Review 2.  Therapeutic strategies in fragile X syndrome: dysregulated mGluR signaling and beyond.

Authors:  Christina Gross; Elizabeth M Berry-Kravis; Gary J Bassell
Journal:  Neuropsychopharmacology       Date:  2011-07-27       Impact factor: 7.853

3.  Magnetization transfer contrast (MTC) and tissue water proton relaxation in vivo.

Authors:  S D Wolff; R S Balaban
Journal:  Magn Reson Med       Date:  1989-04       Impact factor: 4.668

4.  Longitudinal in vivo developmental changes of metabolites in the hippocampus of Fmr1 knockout mice.

Authors:  Da Shi; Su Xu; Jaylyn Waddell; Susanna Scafidi; Steven Roys; Rao P Gullapalli; Mary C McKenna
Journal:  J Neurochem       Date:  2012-11-07       Impact factor: 5.372

5.  Trajectories of early brain volume development in fragile X syndrome and autism.

Authors:  Heather Cody Hazlett; Michele D Poe; Amy A Lightbody; Martin Styner; James R MacFall; Allan L Reiss; Joseph Piven
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2012-08-01       Impact factor: 8.829

Review 6.  Structural polymorphism and multifunctionality of myelin basic protein.

Authors:  George Harauz; Vladimir Ladizhansky; Joan M Boggs
Journal:  Biochemistry       Date:  2009-09-01       Impact factor: 3.162

Review 7.  Pharmacokinetics and side effects of perfluorocarbon-based blood substitutes.

Authors:  S F Flaim
Journal:  Artif Cells Blood Substit Immobil Biotechnol       Date:  1994

8.  Cholesterol for synthesis of myelin is made locally, not imported into brain.

Authors:  H Jurevics; P Morell
Journal:  J Neurochem       Date:  1995-02       Impact factor: 5.372

9.  Minocycline promotes dendritic spine maturation and improves behavioural performance in the fragile X mouse model.

Authors:  T V Bilousova; L Dansie; M Ngo; J Aye; J R Charles; D W Ethell; I M Ethell
Journal:  J Med Genet       Date:  2008-10-03       Impact factor: 6.318

10.  Neuroanatomy of fragile X syndrome is associated with aberrant behavior and the fragile X mental retardation protein (FMRP).

Authors:  Doron Gothelf; Joyce A Furfaro; Fumiko Hoeft; Mark A Eckert; Scott S Hall; Ruth O'Hara; Heather W Erba; Jessica Ringel; Kiralee M Hayashi; Swetapadma Patnaik; Brenda Golianu; Helena C Kraemer; Paul M Thompson; Joseph Piven; Allan L Reiss
Journal:  Ann Neurol       Date:  2008-01       Impact factor: 10.422

View more
  2 in total

1.  PARP1-mediated PARylation activity is essential for oligodendroglial differentiation and CNS myelination.

Authors:  Yan Wang; Yanhong Zhang; Sheng Zhang; Bokyung Kim; Vanessa L Hull; Jie Xu; Preeti Prabhu; Maria Gregory; Veronica Martinez-Cerdeno; Xinhua Zhan; Wenbin Deng; Fuzheng Guo
Journal:  Cell Rep       Date:  2021-10-05       Impact factor: 9.995

2.  Consumption of Breast Milk Is Associated with Decreased Prevalence of Autism in Fragile X Syndrome.

Authors:  Cara J Westmark
Journal:  Nutrients       Date:  2021-05-24       Impact factor: 5.717

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.